New Analysis from Global Industry Analysts Reveals Steady Growth for Healthcare Distribution, with the Market to Reach $3 Trillion Worldwide by 2026

News provided by

Mar 16, 2022, 11:40 ET

SAN FRANCISCO, March 16, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Healthcare Distribution - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE

What's New for 2022?

Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Edition: 9; Released: February 2022

Executive Pool: 732
Companies: 61 - Players covered include Accord-UK Ltd.; ALLIANCE UNICHEM IP LIMITED; AmerisourceBergen Corporation; Attain Med, Inc.; Cardinal Health, Inc.; CuraScript SD; Dakota Drug, Inc.; Express Scripts Holding Company; FedEx Corporation; FFF Enterprises, Inc.; Henry Schein Inc.; KeySource Medical, Inc.; McKesson Corporation; Medline Industries; Morris and Dickson Co., LLC; Mutual Drug; Owens & Minor, Inc.; Patterson Companies Inc.; PHOENIX Group; Redington (India) Limited; Shanghai Pharmaceutical Group Co., Ltd.; Smith Drug Company and Others.
Coverage: All major geographies and key segments
Segments: Product Type (Pharmaceutical, Biopharmaceutical, Medical Devices); End-Use (Retail Pharmacies, Hospital Pharmacies, Other End Uses)
Geographies: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Healthcare Distribution Market to Reach $3 Trillion by 2026
Distribution plays a key role as the distribution network is critical component of the supply chain that ensures the drugs reach the consumers. Proper distribution is a critical component that determines a drug`s commercial success. Drug distribution is a complex process and entails conformance to multiple regulations. In developed markets such as the US, the wholesale market is oligopolistic with a handful of large wholesalers, who sell to regional wholesalers and/or drugstore chains. On the other hand, drug distribution is a complex and fragmented business in most developing markets. The existence of a large number of small wholesalers and the absence of established retail chain networks makes it a complex process in such countries.

Amid the COVID-19 crisis, the global market for Healthcare Distribution estimated at US$1.6 Trillion in the year 2022, is projected to reach a revised size of US$3 Trillion by 2026, growing at a CAGR of 20.2% over the analysis period. Pharmaceuticals, one of the segments analyzed in the report, is projected to grow at a 19.9% CAGR to reach US$1.3 Trillion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biopharmaceuticals segment is readjusted to a revised 22.4% CAGR for the next 7-year period. This segment currently accounts for a 33.7% share of the global Healthcare Distribution market.

The U.S. Market is Estimated at $580 Billion in 2022, While China is Forecast to Reach $522.2 Billion by 2026
The Healthcare Distribution market in the U.S. is estimated at US$580 Billion in the year 2022. The country currently accounts for a 34.81% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$522.2 Billion in the year 2026 trailing a CAGR of 22.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 18.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 20.5% CAGR while Rest of European market (as defined in the study) will reach US$561.3 Billion by the end of the analysis period. Retail pharmacies are a vital link in the drug supply chain as they form the main medium between the manufacturers, wholesalers, and pharmacy benefit managers on the supply side and the retail customers on the other side. Retail pharmacies are also the important cog in the wheel for processing claims of customers. Technology adoption is highly evolved in the US, and claim processing is mostly automated and handled electronically, leading to minimization of paper based manual processing, and maximization of efficiency.

Medical Devices Segment to Reach $612.3 Billion
During the pandemic, wearable devices such as fitness bands have gained increased popularity for providing real time patient information to the service providers in the industry. Remote monitoring systems use the data collected from wearable gadgets to provide medical care to patients who have recovered and do not need to be in hospital. Devices connected with wearable gadgets trace and transmit data related to patients' medical records through mobile applications, voice enabled platforms for follow-up of such patients. Considering this upwards trend, healthcare providers are expecting huge investments and technological intervention in wearable gadgets, remote monitoring systems and health sensor techniques. In the global Medical Devices segment, USA, Canada, Japan, China and Europe will drive the 17.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$169.4 Billion will reach a projected size of US$510.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$76.2 Billion by the year 2026, while Latin America will expand at a 17.4% CAGR through the analysis period. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

SOURCE Global Industry Analysts, Inc.